-
1
-
-
78649888517
-
European Atherosclerosis Society Consensus Panel. Lipoprotein(a) as a cardiovascular risk factor: current status
-
Nordestgaard B.G., Chapman M.J., Ray K., Borén J., Andreotti F., Watts G.F., et al. European Atherosclerosis Society Consensus Panel. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J 2010, 31:2844-2853.
-
(2010)
Eur Heart J
, vol.31
, pp. 2844-2853
-
-
Nordestgaard, B.G.1
Chapman, M.J.2
Ray, K.3
Borén, J.4
Andreotti, F.5
Watts, G.F.6
-
2
-
-
33746208054
-
Relation Between Lipoprotein(a) and Fibrinogen and Serial Intravascular Ultrasound Plaque Progression in Left Main Coronary Arteries
-
Hartmann M., von Birgelen C., Mintz G., Stoel M.G., Eggebrecht H., Wieneke H., et al. Relation Between Lipoprotein(a) and Fibrinogen and Serial Intravascular Ultrasound Plaque Progression in Left Main Coronary Arteries. J Am Coll Cardiol 2006, 48:446-452.
-
(2006)
J Am Coll Cardiol
, vol.48
, pp. 446-452
-
-
Hartmann, M.1
von Birgelen, C.2
Mintz, G.3
Stoel, M.G.4
Eggebrecht, H.5
Wieneke, H.6
-
3
-
-
67049167090
-
Genetically elevated lipoprotein(a) and increased risk of myocardial infarction
-
Kamstrup P.R., Tybjaerg-Hansen A., Steffensen R., Nordestgaard B.G. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 2009, 301:2331-2339.
-
(2009)
JAMA
, vol.301
, pp. 2331-2339
-
-
Kamstrup, P.R.1
Tybjaerg-Hansen, A.2
Steffensen, R.3
Nordestgaard, B.G.4
-
4
-
-
67651210632
-
Emerging Risk Factors Collaboration. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality
-
Emerging Risk Factors Collaboration
-
Erqou S., Kaptoge S., Perry P.L., Di Angelantonio E., Thompson A., White I.R., et al. Emerging Risk Factors Collaboration. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 2009, 302:412-423. Emerging Risk Factors Collaboration.
-
(2009)
JAMA
, vol.302
, pp. 412-423
-
-
Erqou, S.1
Kaptoge, S.2
Perry, P.L.3
Di Angelantonio, E.4
Thompson, A.5
White, I.R.6
-
5
-
-
0033554451
-
Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study
-
Kronenberg F., Kronenberg M.F., Kiechl S., Trenkwalder E., Santer P., Oberhollenzer F., et al. Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study. Circulation 1999, 100:1154-1160.
-
(1999)
Circulation
, vol.100
, pp. 1154-1160
-
-
Kronenberg, F.1
Kronenberg, M.F.2
Kiechl, S.3
Trenkwalder, E.4
Santer, P.5
Oberhollenzer, F.6
-
6
-
-
33845465759
-
Elevated Lipoprotein(a) does not promote early atherosclerotic changes of the carotid arteries in young, healthy adults
-
Grebe M.T., Schoene E., Schaefer C.A., Boedeker R.H., Kemkes-Matthes B., Voss R., et al. Elevated Lipoprotein(a) does not promote early atherosclerotic changes of the carotid arteries in young, healthy adults. Atherosclerosis 2007, 190:194-198.
-
(2007)
Atherosclerosis
, vol.190
, pp. 194-198
-
-
Grebe, M.T.1
Schoene, E.2
Schaefer, C.A.3
Boedeker, R.H.4
Kemkes-Matthes, B.5
Voss, R.6
-
7
-
-
84886948388
-
Carotid intima-media thickness in asymptomatic subjects with low lipoprotein(a) levels
-
Kotani K., Sakane N. Carotid intima-media thickness in asymptomatic subjects with low lipoprotein(a) levels. J Clin Med Res. 2012, 4:130-134.
-
(2012)
J Clin Med Res.
, vol.4
, pp. 130-134
-
-
Kotani, K.1
Sakane, N.2
-
8
-
-
61549101898
-
Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein (a) levels and prevent major adverse coronary events
-
Group of Clinical Investigators
-
Jaeger B.R., Richter Y., Nagel D. Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein (a) levels and prevent major adverse coronary events. Nat. Clin. Pract. Cardiovasc. Med 2009, 6:229-239. Group of Clinical Investigators.
-
(2009)
Nat. Clin. Pract. Cardiovasc. Med
, vol.6
, pp. 229-239
-
-
Jaeger, B.R.1
Richter, Y.2
Nagel, D.3
-
9
-
-
84890904215
-
Lipoprotein apheresis in patients with maximally tolerated lipid-lowering therapy, lipoprotein(a)-hyperlipoproteinemia, and progressive cardiovascular disease: prospective observational multicenter study
-
Pro(a)LiFe Study Group
-
Leebmann J., Roeseler E., Julius U., Heigl F., Spitthoever R., Heutling D., et al. Lipoprotein apheresis in patients with maximally tolerated lipid-lowering therapy, lipoprotein(a)-hyperlipoproteinemia, and progressive cardiovascular disease: prospective observational multicenter study. Circulation 2013, 128:2567-2576. Pro(a)LiFe Study Group.
-
(2013)
Circulation
, vol.128
, pp. 2567-2576
-
-
Leebmann, J.1
Roeseler, E.2
Julius, U.3
Heigl, F.4
Spitthoever, R.5
Heutling, D.6
-
10
-
-
84872876060
-
Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography
-
Safarova M.S., Ezhov M.V., Afanasieva O.I., Matchin Y.G., Atanesyan R.V., Adamova I.Y., et al. Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography. Atheroscler Suppl. 2013, 14(1):93-99.
-
(2013)
Atheroscler Suppl.
, vol.14
, Issue.1
, pp. 93-99
-
-
Safarova, M.S.1
Ezhov, M.V.2
Afanasieva, O.I.3
Matchin, Y.G.4
Atanesyan, R.V.5
Adamova, I.Y.6
-
11
-
-
0016998022
-
Grading of angina pectoris (Letter to the Editor)
-
Campeau L. Grading of angina pectoris (Letter to the Editor). Circulation 1976, 54:522-523.
-
(1976)
Circulation
, vol.54
, pp. 522-523
-
-
Campeau, L.1
-
12
-
-
38849140265
-
Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine
-
American Society of Echocardiography Carotid Intima-Media Thickness Task Force
-
Stein J.H., Korcarz C.E., Hurst R.T., Lonn E., Kendall C.B., Mohler E.R., et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr 2008, 21:93-111. American Society of Echocardiography Carotid Intima-Media Thickness Task Force.
-
(2008)
J Am Soc Echocardiogr
, vol.21
, pp. 93-111
-
-
Stein, J.H.1
Korcarz, C.E.2
Hurst, R.T.3
Lonn, E.4
Kendall, C.B.5
Mohler, E.R.6
-
13
-
-
84868239835
-
Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011
-
Touboul P.J., Hennerici M.G., Meairs S., Adams H., Amarenco P., Bornstein N., et al. Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis 2012, 34:290-296.
-
(2012)
Cerebrovasc Dis
, vol.34
, pp. 290-296
-
-
Touboul, P.J.1
Hennerici, M.G.2
Meairs, S.3
Adams, H.4
Amarenco, P.5
Bornstein, N.6
-
14
-
-
33947713026
-
Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial
-
Crouse J.R., Raichlen J.S., Riley W.A., Evans G.W., Palmer M.K., O'Leary D.H., et al. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. JAMA 2007, 297:1344-1353.
-
(2007)
JAMA
, vol.297
, pp. 1344-1353
-
-
Crouse, J.R.1
Raichlen, J.S.2
Riley, W.A.3
Evans, G.W.4
Palmer, M.K.5
O'Leary, D.H.6
-
15
-
-
84921509674
-
Lipoprotein(a) level and apolipoprotein(a) phenotype as predictors of long-term cardiovascular outcomes after coronary artery bypass grafting
-
Ezhov M.V., Safarova M.S., Afanasieva O.I., Kukharchuk V.V., Pokrovsky S.N. Lipoprotein(a) level and apolipoprotein(a) phenotype as predictors of long-term cardiovascular outcomes after coronary artery bypass grafting. Atherosclerosis 2014, 235:477-482.
-
(2014)
Atherosclerosis
, vol.235
, pp. 477-482
-
-
Ezhov, M.V.1
Safarova, M.S.2
Afanasieva, O.I.3
Kukharchuk, V.V.4
Pokrovsky, S.N.5
-
16
-
-
0033811877
-
The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels
-
Kroon A.A., van't Hof M.A., Demacker P.N., Stalenhoef A.F. The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels. Atherosclerosis 2000, 152:519-526.
-
(2000)
Atherosclerosis
, vol.152
, pp. 519-526
-
-
Kroon, A.A.1
van't Hof, M.A.2
Demacker, P.N.3
Stalenhoef, A.F.4
-
17
-
-
84881381644
-
Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue
-
Schwartz J., Winters J.L., Padmanabhan A., Balogun R.A., Delaney M., Linenberger M.L., et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher 2013, 28:145-284.
-
(2013)
J Clin Apher
, vol.28
, pp. 145-284
-
-
Schwartz, J.1
Winters, J.L.2
Padmanabhan, A.3
Balogun, R.A.4
Delaney, M.5
Linenberger, M.L.6
-
18
-
-
0027954604
-
Extracorporeal immunoadsorbtion for the specific removal of lipoprotein (a) [Lp(a) apheresis]: preliminary clinical data
-
Pokrovsky S.N., Sussekov A.V., Afanasieva O.I., Adamova I.Y., Lyakishev A.A., Kukharchuk V.V. Extracorporeal immunoadsorbtion for the specific removal of lipoprotein (a) [Lp(a) apheresis]: preliminary clinical data. Chem. Phys. Lipids 1994, 67/68:323-330.
-
(1994)
Chem. Phys. Lipids
, pp. 323-330
-
-
Pokrovsky, S.N.1
Sussekov, A.V.2
Afanasieva, O.I.3
Adamova, I.Y.4
Lyakishev, A.A.5
Kukharchuk, V.V.6
-
19
-
-
0029994827
-
Low-density lipoprotein apheresis in the treatment of two patients with coronary heart disease and extremely elevated lipoprotein(a) levels
-
Bambauer R., Schiel R., Keller H.E., Klinkmann J., Latza R. Low-density lipoprotein apheresis in the treatment of two patients with coronary heart disease and extremely elevated lipoprotein(a) levels. Artif Organs 1996, 20:340-343.
-
(1996)
Artif Organs
, vol.20
, pp. 340-343
-
-
Bambauer, R.1
Schiel, R.2
Keller, H.E.3
Klinkmann, J.4
Latza, R.5
-
20
-
-
0347874855
-
Lipoprotein(a)-apheresis in the secondary prevention of coronary heart disease
-
Ullrich H., Lackner K., Schmitz G. Lipoprotein(a)-apheresis in the secondary prevention of coronary heart disease. Transfus Sci. 1996, 17:511-517.
-
(1996)
Transfus Sci.
, vol.17
, pp. 511-517
-
-
Ullrich, H.1
Lackner, K.2
Schmitz, G.3
-
21
-
-
74749107585
-
Efficacy criteria and cholesterol targets for LDL apheresis
-
Thompson G.R., Barbir M., Davies D., Dobral P., Gesinde M., Livingston M., et al. Efficacy criteria and cholesterol targets for LDL apheresis. Atherosclerosis 2010, 208:317-321.
-
(2010)
Atherosclerosis
, vol.208
, pp. 317-321
-
-
Thompson, G.R.1
Barbir, M.2
Davies, D.3
Dobral, P.4
Gesinde, M.5
Livingston, M.6
-
22
-
-
0034159755
-
Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study
-
Chambless L.E., Folsom A., Clegg L.X., Sharrett A.R., Shahar E., Nieto F.J., et al. Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 2000, 151:478-487.
-
(2000)
Am J Epidemiol
, vol.151
, pp. 478-487
-
-
Chambless, L.E.1
Folsom, A.2
Clegg, L.X.3
Sharrett, A.R.4
Shahar, E.5
Nieto, F.J.6
-
23
-
-
0035941786
-
Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial
-
Smilde T.J., van Wissen S., Wollersheim H., Trip M.D., Kastelein J.J., Stalenhoef A.F. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial. Lancet 2001, 357:577-581.
-
(2001)
Lancet
, vol.357
, pp. 577-581
-
-
Smilde, T.J.1
van Wissen, S.2
Wollersheim, H.3
Trip, M.D.4
Kastelein, J.J.5
Stalenhoef, A.F.6
-
24
-
-
33846609195
-
Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis
-
Lorenz M.W., Markus H.S., Bots M.L., Rosvall M., Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007, 115:459-467.
-
(2007)
Circulation
, vol.115
, pp. 459-467
-
-
Lorenz, M.W.1
Markus, H.S.2
Bots, M.L.3
Rosvall, M.4
Sitzer, M.5
-
25
-
-
0029882936
-
LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis
-
Kroon A.A., Aengevaeren W.R., van der Werf T., Uijen G.J., Reiber J.H., Bruschke A.V., Stalenhoef A.F. LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis. Circulation 1996, 93:1826-1835.
-
(1996)
Circulation
, vol.93
, pp. 1826-1835
-
-
Kroon, A.A.1
Aengevaeren, W.R.2
van der Werf, T.3
Uijen, G.J.4
Reiber, J.H.5
Bruschke, A.V.6
Stalenhoef, A.F.7
-
26
-
-
0029096765
-
Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries
-
Salonen R., Nyyssönen K., Porkkala E., Rummukainen J., Belder R., Park J.S., Salonen J.T. Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation 1995, 92:1758-1764.
-
(1995)
Circulation
, vol.92
, pp. 1758-1764
-
-
Salonen, R.1
Nyyssönen, K.2
Porkkala, E.3
Rummukainen, J.4
Belder, R.5
Park, J.S.6
Salonen, J.T.7
-
27
-
-
80052384849
-
[Pleiotropic effects of nicotinic acid therapy in men with coronary heart disease and elevated lipoprotein(a) levels]
-
[Russian]
-
Safarova M.S., Trukhacheva E.P., Ezhov M.V., Afanas'eva O.I., Afanas'eva M.I., Tripoten' M.I., et al. [Pleiotropic effects of nicotinic acid therapy in men with coronary heart disease and elevated lipoprotein(a) levels]. Kardiologiia 2011, 51(5):9-16. [Russian].
-
(2011)
Kardiologiia
, vol.51
, Issue.5
, pp. 9-16
-
-
Safarova, M.S.1
Trukhacheva, E.P.2
Ezhov, M.V.3
Afanas'eva, O.I.4
Afanas'eva, M.I.5
Tripoten', M.I.6
-
28
-
-
79960205374
-
European Society of Cardiology (ESC); European Atherosclerosis Society (EAS). ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
-
Catapano A.L., Reiner Z., De Backer G., Graham I., Taskinen M.R., Wiklund O., et al. European Society of Cardiology (ESC); European Atherosclerosis Society (EAS). ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis 2011, 217:3-46.
-
(2011)
Atherosclerosis
, vol.217
, pp. 3-46
-
-
Catapano, A.L.1
Reiner, Z.2
De Backer, G.3
Graham, I.4
Taskinen, M.R.5
Wiklund, O.6
|